Vir Biotechnology, Inc. (VIR) Covered Calls
You can sell covered calls on Vir Biotechnology, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VIR (prices last updated Wed 4:16 PM ET):
| Vir Biotechnology, Inc. (VIR) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 7.16 | -0.20 | 7.01 | 7.20 | 1.0M | - | 1.0 |
| Covered Calls For Vir Biotechnology, Inc. (VIR) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Dec 20 | 7.5 | 0.00 | 7.20 | 0.0% | 0.0% | |
| Jan 17 | 7.5 | 0.85 | 6.35 | 13.4% | 158% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.
| Top 10 Open Interest For Dec 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | EEM covered calls | 1. | NVDA covered calls | |
| 2. | SPY covered calls | 7. | IWM covered calls | 2. | RGTI covered calls | |
| 3. | XLF covered calls | 8. | KWEB covered calls | 3. | QUBT covered calls | |
| 4. | QQQ covered calls | 9. | TLT covered calls | 4. | MU covered calls | |
| 5. | FXI covered calls | 10. | TSLA covered calls | 5. | QBTS covered calls | |
Want more examples? VIPS Covered Calls | VIRT Covered Calls
